AI assistant
Bliss GVS Pharma Limited — Major Shareholding Notification 2021
Apr 19, 2021
61284_rns_2021-04-19_9ef5ecbf-4048-4cf9-a424-2f2d0d3c6b94.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Shruti Vishal Rao
102, Hyde Park Saki Vihar Road, Andheri (E), Митбаі - 400 072, ІДДІЯ. [email protected]
Date: April 09, 2021
| To, | To, | To, |
|---|---|---|
| Corporate Relationship Dept., | Listing Department, | Bliss GVS Pharma Limited |
| BSE Limited, | National Stock Exchange of | 102, Hyde Park, Saki Vihar |
| Phiroze Jeejeebhov Towers, | India Ltd., | Andheri (East). Road. |
| Dalal Street, | Exchange Plaza, C-1, Block G, | Mumbai - 400072. |
| Mumbai-400001. | Bandra Kurla Complex, | |
| Scrip Code: 506197 | Bandra (E). Mumbai-400 051 | |
| Symbol: BLISSGVS |
Subject: Annual Disclosure pursuant to Regulation 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Dear Sir/Madam,
Please find enclosed herewith the disclosure as required in terms of Regulation 30(2) SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended from time to time.
Kindly acknowledge receipt of the same.
Thanking You,
trainath Vishal Rao ATTTN
Promoter
Encl: Disclosure
Shruti Vishal Rao
102, Hyde Park Saki Vihar Road, Andheri (E), Митбаі - 400 072, ІДДІЯ. [email protected]
Disclosures under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
| 1. Name of the Target Company (TC) | BLISS GVS PHARMA LIMITED | ||
|---|---|---|---|
| 2. Name(s) of the stock exchange(s) | BSE Limited | ||
| where the shares of the TC are listed | National Stock Exchange of India Limited | ||
| 3. Particulars of the shareholder(s): a. Name of person(s) together with Persons Acting in Concert (PAC) whose total holding (including that in form shares, warrants, $\sigma$ the convertible securities and any other instrument that would entitle the holder to receive shares in the TC) is more than 25% of the voting rights of the TC. |
Not Applicable | ||
| Οľ | |||
| b. Name(s) of promoter(s), member of the promoter group and PAC with him. 4. Particulars of the shareholding of person(s) mentioned at (3) above |
Shruti Vishal Rao Narsimha Shibroor Kamath (S. N. Kamath) Vibha Gagan Sharma Gagan Harsh Sharma Number $\%$ of % of total diluted w.r.t. total shares share/voting /voting share |
||
| capital wherever applicable |
capital of TC (*) | ||
| As of March 31st 2021, holding of: | |||
| a) Shares | #3,43,57,024 | 33.31% | NA |
| b) Voting Rights (otherwise than by shares) |
NA | NA | NA |
| c) Warrants, | NA | NA | NA |
| d) Convertible Securities | NA | NA | NA |
| e) Any other instrument that would entitle the holder to receive shares in the TC. |
NA | NA | NA |
| Total | 3,43,57,024 | 33.31% | NA |
Part-A- Details of Shareholding:
Gramath
Shruti Vishal Rao
102, Hyde Park, Saki Vihar Road, Andheri (E), Митбаі - 400 072, INDIA. [email protected]
(#) Out of 3,43,57,024 Equity Shares mentioned above, I Shruti Rao, Promoter of the company individually holds (0) Equity Shares which stands (0.00%) of total paid up capital of the Company.
Part-B**
Name of the Target Company: BLISS GVS PHARMA LIMITED
| Name(s) of the person and Persons Acting in Concert (PAC) with the person |
Whether the person belongs to Promoter/ Promoter group |
PAN of the person and PACs |
|---|---|---|
| Narsimha Shibroor Kamath | Yes | |
| Vibha Gagan Sharma | Yes | |
| Gagan Harsh Sharma | Yes | |
| Shruti Vishal Rao | Yes |
Shruti dishal Rao Promoter
Place: Mumbai Date: April 09, 2021
Note:
- In case of promoter(s) making disclosure under regulation 30(2), no additional disclosure under regulation 30(1) is required.
(*) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.
(**) Part-B shall be disclosed to the Stock Exchanges but shall not be disseminated.
Shruti Vishal Rao
102, Hyde Park, Saki Vihar Road, Andheri (E), Митбаі - 400 072, ІДДІЯ. [email protected]
Date: April 09, 2021
| To, | Tо, | To, | |
|---|---|---|---|
| Corporate Relationship Dept., | Listing Department, | Audit Committee | |
| BSE Limited, | National Stock Exchange of | Bliss GVS Pharma Limited | |
| Phiroze Jeejeebhoy Towers, | India Ltd., | 102, Hyde Park, Saki Vihar | |
| Dalal Street, | Exchange Plaza, C-1, Block G, | Andheri Road, (East). |
|
| Mumbai-400001. | Bandra Kurla Complex, | Mumbai - 400072. | |
| Scrip Code: 506197 | Bandra (E). Mumbai-400 051 | ||
| Symbol: BLISSGVS | 93 |
Subject: Declaration under Regulation 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011- Yearly Disclosure
Dear Sir/Madam,
Pursuant to the Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011, I, Shruti Vishal Rao being Promoter of Bliss GVS Pharma Limited, do hereby declare that, I along with person acting in concert with me have not made any encumbrance, directly or indirectly on any shares of Bliss GVS Pharma Limited other than those already disclosed during the financial year to BSE Limited & National Stock Exchange of India Ltd, and to the Audit Committee of the Company.
Further as of March 31, 2021, the Number of encumbered shares by me of Bliss GVS Pharma Limited is - Nil.
Shruti Vishal Rao Promoter
Place: Mumbai